About: Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $65.69 (-3.89%)
SLGL NASDAQ Sol Gel Technologies Ltd
Sol Gel Technologies Ltd share price
SLGL price activity
Last Price
$65.690
Change (24hr)
-2.66 USD (3.89%)
Volume
55.91K
Volume (4w avg)
-
Open
$67.29
Day Range
$63.98 - $70.06
Previous Close
$68.35
Last Trade
02 Nov, 9:00 pm GMT+0
Delayed
02 Nov, 9:00 pm GMT+0
SLGL price performance
Delayed
02 Nov, 9:00 pm GMT+0
SLGL Market Signals